Application 217003

Type
NDA
Sponsor
PHARMACYCLICS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IMBRUVICAIBRUTINIBSUSPENSION;ORAL70MG/MLNoNo
002IMBRUVICAIBRUTINIBCAPSULE;ORAL70MGNoNo
003IMBRUVICAIBRUTINIBCAPSULE;ORAL140MGNoNo
004IMBRUVICAIBRUTINIBTABLET;ORAL140MGNoNo
005IMBRUVICAIBRUTINIBTABLET;ORAL230MGNoNo
006IMBRUVICAIBRUTINIBTABLET;ORAL420MGNoNo
007IMBRUVICAIBRUTINIBTABLET;ORAL560MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
57962-007ImbruvicaIbrutinibPharmacyclics LLCNDACurrent
57962-007ImbruvicaIbrutinibPharmacyclics LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83995SUPPL 2025-10-31
83883SUPPL 2025-10-23
80732SUPPL 2024-12-26
80728SUPPL 2024-12-26
78464SUPPL 2024-05-14
77610SUPPL 2024-02-23
77609SUPPL 2024-02-23
74474ORIG 2023-06-12
73810ORIG 2023-03-21
71891ORIG2022-08-25